Myringotomy and Tympanostomy Tube Placement

wRVU1.96
Global10-day
ApproachOtologic Microscope
ComplexityRoutine

Recurrent acute otitis media / chronic otitis media with effusion / eustachian tube dysfunction

Same

Bilateral myringotomy and tympanostomy tube placement

[***, MD/DO]

[Resident/Fellow/PA name]

General inhalational (mask) / local

Patient presents with [recurrent AOM (≥3 episodes in 6 months or ≥4 episodes in 12 months, with middle ear effusion present at time of assessment) / chronic bilateral OME ≥3 months with conductive hearing loss, speech delay, or at-risk condition (Down syndrome, cleft palate, ASD, craniofacial anomaly)]. [Bilateral] middle ear effusion confirmed on [pneumatic otoscopy / tympanometry]. Conservative management for [X months] failed. Risks including persistent perforation, tube extrusion, and otorrhea discussed. Consent obtained.

Bilateral tympanic membranes [dull / retracted / with effusion]. [Amber / grey] effusion present bilaterally. [Fluid expressed on myringotomy: serous / mucoid / purulent.] Landmarks [visible / obscured]. No cholesteatoma.

The patient was brought to the operating room. Inhalational general anesthesia administered via mask [without intubation]. The patient was positioned supine and the ear canal cleaned under the operating microscope.

RIGHT EAR: The ear canal was cleaned of cerumen. The tympanic membrane was visualized with the operating microscope. A radial myringotomy incision was made in the anteroinferior quadrant using a myringotomy knife. [Effusion aspirated with a Baron suction.] A [Reuter Bobbin / Armstrong / T-tube] tympanostomy tube was placed through the myringotomy using alligator forceps. Position confirmed in the myringotomy, tube [patent].

LEFT EAR: Same procedure performed in mirror fashion.

Both ears inspected. Tubes patent and in good position. [Antibiotic otic drops instilled bilaterally at end of procedure.] Patient awakened without difficulty.

None

Middle ear fluid [sent for culture / discarded]

Minimal

Bilateral tympanostomy tubes in place

Patient taken to PACU. Discharged same day.

Epic SmartPhrase Version
PREOPERATIVE DIAGNOSIS: [Recurrent acute otitis media / chronic otitis media with effusion / eustachian tube dysfunction]
POSTOPERATIVE DIAGNOSIS: Same
PROCEDURE PERFORMED: Bilateral myringotomy and tympanostomy tube placement
ATTENDING SURGEON: ***, MD/DO
FIRST ASSISTANT: ***
ANESTHESIA: General inhalational (mask)

INDICATIONS: The patient is a .PTAGE-year-old .PTSEX with [recurrent AOM (*** episodes in *** months, with middle ear effusion confirmed at time of assessment) / chronic bilateral OME ≥*** months with conductive hearing loss / speech delay / at-risk condition]. Bilateral middle ear effusion confirmed on pneumatic otoscopy and tympanometry. Conservative management for *** months failed. Risks including persistent perforation, tube extrusion, and otorrhea were discussed. Informed consent obtained.

FINDINGS: Bilateral tympanic membranes dull and retracted. [Amber / mucoid] effusion present bilaterally. Landmarks visible. No cholesteatoma.

DESCRIPTION OF PROCEDURE:
The patient was taken to the OR; inhalational general anesthesia administered via mask without intubation. Positioned supine. RIGHT EAR: Ear canal cleaned under operating microscope. Tympanic membrane visualized. Radial myringotomy incision made in the anteroinferior quadrant. Effusion aspirated with Baron suction. A [Reuter Bobbin / Armstrong] tympanostomy tube placed through the myringotomy with alligator forceps, confirmed patent and in good position. LEFT EAR: Same procedure performed in mirror fashion. Both tubes confirmed patent. Antibiotic otic drops instilled bilaterally. Patient awakened without difficulty.

ESTIMATED BLOOD LOSS: Minimal
SPECIMENS: Middle ear fluid [sent for culture / discarded]
COMPLICATIONS: None
DRAINS: Bilateral tympanostomy tubes in place
DISPOSITION: Patient taken to PACU. Discharged same day.

Signed: .ME, .MYDEGREE
.TODAY
Variants

T-tube placement

For chronic Eustachian tube dysfunction. T-tubes remain for several years. Document tube type and placement site.

In-office with automated delivery device (Tula System / Hummingbird TTS)

In-office procedure with topical anesthesia. FDA-cleared for patients ≥6 months old (not adult-only). Document which device was used, anesthesia adequacy, and tube placement.

Tube removal

Document tube location, removal technique (alligator forceps), and tympanic membrane status.

Charting Tips
  1. Document tube type (short-term grommet vs. long-term T-tube — affects expected dwell time and follow-up plan)
  2. State fluid character (serous, mucoid, purulent) — affects postoperative antibiotic decisions
  3. Document that tube is patent and in correct quadrant (anteroinferior is standard)
  4. Document otic drops if instilled at end of case
  5. Bilateral placement: use bilateral-procedure reporting for most payers (single line), but verify — some Medicaid/commercial payers require RT/LT modifiers on separate lines
  6. Per 2022 AAO-HNS CPG: document that MEE was confirmed at time of surgical assessment (required for recurrent AOM indication), and document OME duration (≥3 months for chronic OME indication)
Documentation & Reimbursement Considerations
  1. Primary service: Report Myringotomy and Tympanostomy Tube Placement as the primary service when it is the definitive operation performed.
  2. This is the primary service for most pediatric bilateral tube placements.
  3. Use for in-office adult procedures or awake procedures.
  4. Medicare and many commercial payers reimburse at 150% for the bilateral modifier. However, some state Medicaid and commercial payers require two separate lines with RT/LT modifiers — verify payer-specific requirements.
  5. Subsequent tube checks and audiograms are separately billable after the global period.
  6. The primary service requires general anesthesia as an integral part — do not use for in-office tube removal without GA; report an E/M instead.
  7. In-office tube placement with automated delivery devices: coding differs by device.

ⓘ General Documentation & Reimbursement Considerations →